Benjamin P Linas
Affiliation: Boston University School of Medicine
- Cost-effective screening for acute hepatitis C virus infection in HIV-infected men who have sex with menBenjamin P Linas
HIV Epidemiology and Outcomes Research Unit, Section of Infectious Diseases, Boston Medical Center, Boston, MA 02118, USA
Clin Infect Dis 55:279-90. 2012..We used a Monte Carlo computer simulation to estimate the effectiveness and cost-effectiveness of screening for acute hepatitis C virus (HCV) infection in human immunodeficiency virus (HIV)-infected men who have sex with men...
- Priorities for screening and treatment of latent tuberculosis infection in the United StatesBenjamin P Linas
HIV Epidemiology and Outcomes Research Unit, Boston Medical Center, Section of Infectious Disease, Evans Biomedical Research Center, 650 Albany St Rm 647, Boston, MA 02118, USA
Am J Respir Crit Care Med 184:590-601. 2011..To improve the effectiveness of tuberculosis (TB) control programs in the United States by identifying cost-effective priorities for screening for latent tuberculosis infection (LTBI)...
- Improving outcomes in state AIDS drug assistance programsBenjamin P Linas
Divisions of General Medicine, Massachusetts General Hospital, Boston, MA 02115, USA
J Acquir Immune Defic Syndr 51:513-21. 2009..State AIDS Drug Assistance Programs (ADAPs) provide antiretroviral medications to patients with no access to medications. Resource constraints limit the ability of many ADAPs to meet demand for services...
- When to start antiretroviral therapy in resource-limited settingsRochelle P Walensky
Massachusetts General Hospital, Brigham and Women s Hospital, Harvard University Medical School, Harvard School of Public Health, and Boston University School of Public Health, Boston, Massachusetts 02114, USA
Ann Intern Med 151:157-66. 2009..The results of international clinical trials that are assessing when to initiate antiretroviral therapy (ART) will not be available for several years...
- Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DCRochelle P Walensky
Division of Infectious Disease, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA
Clin Infect Dis 51:392-400. 2010..We forecast outcomes of this approach if implemented in Washington DC...
- Optimizing resource allocation in United States AIDS drug assistance programsBenjamin P Linas
Division of General Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA
Clin Infect Dis 43:1357-64. 2006..We hypothesized that CD4 cell count-based ADAP eligibility would improve ADAP outcomes, allowing them to serve more-diverse patient populations and to prioritize persons who are at greatest risk of HIV-related mortality...
- The cost-effectiveness of improved hepatitis C virus therapies in HIV/hepatitis C virus coinfected patientsBenjamin P Linas
aSection of Infectious Diseases, Department of Medicine, Boston Medical Center bDepartment of Epidemiology, Boston University School of Public Health, Boston, Massachusetts cDepartment of Public Health, Weill Cornell Medical College, New York, New York dDivision of General Medicine, Massachusetts General Hospital eDivision of Infectious Diseases, Massachusetts General Hospital fDepartment of Global Health and Population gDepartment of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts, USA
AIDS 28:365-76. 2014..To evaluate the effectiveness and cost-effectiveness of strategies to treat hepatitis C virus (HCV) in HIV/HCV coinfected patients in the United States...
- Cost-effectiveness of surveillance strategies after treatment for high-grade anal dysplasia in high-risk patientsSabrina A Assoumou
Department of Medicine, Section of Infectious Diseases, Boston University School of Medicine, Boston, MA 02118, USA
Sex Transm Dis 40:298-303. 2013..Currently, there is no consensus on posttreatment surveillance of HIV-infected men who have sex with men (MSM) who have been treated for high-grade intraepithelial neoplasia (HGAIN), the likely precursor to anal cancer...
- First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trialAndrea L Ciaranello
Division of Infectious Disease, Massachusetts General Hospital, Boston, 02114, USA
AIDS 25:479-92. 2011..nevirapine-based antiretroviral therapy (ART) among women previously exposed to single-dose nevirapine to prevent mother-to-child HIV transmission. However, lopinavir/ritonavir is 12 times costlier than nevirapine...
- Assessing the impact of federal HIV prevention spending on HIV testing and awarenessBenjamin P Linas
Massachusetts General Hospital, 50 Staniford St, Ninth Floor, Boston, MA 02114, USA
Am J Public Health 96:1038-43. 2006..The United States allocates more than $900 million annually for the prevention of HIV infection. We assessed the impact of this funding on HIV testing and knowledge...